Average Co-Inventor Count = 7.33
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (33 from 2,405 patents)
2. Merck + Co., Inc. (5 from 4,770 patents)
3. Metabasis Therapeutics, Inc. (1 from 63 patents)
38 patents:
1. 11230543 - Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
2. 11207312 - Metallo-beta-lactamase inhibitors and methods of use thereof
3. 11104690 - Indazole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
4. 10947222 - Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
5. 10544130 - Metallo-beta-lactamase inhibitors
6. 10513518 - Inhibitors of the renal outer medullary potassium channel
7. 10407421 - Bicyclic aryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
8. 10227331 - Metallo-β-lactamase inhibitors
9. 10221163 - Metallo-beta-lactamase inhibitors
10. 10208064 - Inhibitors of the renal outer medullary potassium channel
11. 10000484 - Inhibitors of the renal outer medullary potassim channel
12. 9862720 - Inhibitors of the renal outer medullary potassium channel
13. 9850245 - Inhibitors of the renal outer medullary potassium channel
14. 9839629 - Inhibitors of the renal outer medullary potassium channel
15. 9765074 - Inhibitors of the renal outer medullary potassium channel